You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1701 to 1725 of about 6058
Next 25
01/25/2017
Correction to: Brain Surgery Made Safer With New Smart Needle
DelMar Pharmaceuticals and MD Anderson Initiate New Phase Two Clinical Trial of VAL-083 for MGMT-unmethylated Recurrent Glioblastoma Multiforme (GBM)
‘Tumor Shrinking’ Drug Shows Promise In Dogs Before Clinical Trials On Humans
Antiangiogenic treatments prolong OS in glioblastoma subgroup
Combination therapy for glioblastoma shows promising results in early-stage research
01/24/2017
Norton, UK Partner on Clinical Trial for First-Ever Treatment of Radiation Necrosis
Quick Survey For GBM patients
Brain Surgery Made Safer With New Smart Needle
01/23/2017
The Musella Foundation announced that it has awarded a $10,000 brain tumor research grant
Musella Foundation Request for Brain Tumor Research Grant Proposals
01/19/2017
Musella Foundation Copayment Assistance Program is now closed to new patients
Agenus announces collaboration with the National Cancer Institute to evaluate the combination of Pembrolizumab (Keytruda®, Merck & Co., Inc.) with Prophage™ (Agenus Inc.) autologous vaccine
New Study Aims to Extend TTFields Beyond Grade IV Brain Cancer Domain
Glioblastoma Treatment Breakthrough: `Untreatable` Brain Cancer Tumor Stabilized With Malaria Drug
Novocure’s Optune® Now Available at 500 Cancer Treatment Centers in the U.S.
01/15/2017
Immunotherapies for GBM: Tumor Vaccines by Linda Liau, M.D., Ph.D., M.B.A.
01/14/2017
National Walk To End Brain Tumors – Volunteers needed
01/13/2017
Salmonella Has Been Genetically Engineered to Consume Brain Tumors
01/03/2017
Musella Foundation Copay Assistance Program reopens!
12/31/2016
Florescent light helps surgeons target brain tumors
Pathway linked to slower aging also fuels brain cancer
Prognostic parameters and outcome after re-irradiation for progressive glioblastoma.
A Rational Approach to Target the Epidermal Growth Factor Receptor in Glioblastomas.
Absence of cytomegalovirus in glioblastoma and other high-grade gliomas by real-time PCR, immunohistochemistry and in situ hybridization.
Top Brain Tumor News Stories for 2016